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Discrimination between equals in the future: The selective oxidation of glycosides and 
aminoglycosides allows selective modification of carbohydrates and antibiotics in a minimum 
amount of synthetic steps. In this chapter, several future prospects for the selective oxidation of 
carbohydrates are discussed. A new concept to enhance catalyst stability by deuteration is 
introduced. Possible complexes and ligands, new substrates, such as natural sweeteners, together 







Future Perspectives in the Selective 





This thesis describes a strategy for the selective oxidation and 
modification of carbohydrates and aminoglycoside antibiotics. The high 
regioselectivity allows straightforward modification of carbohydrates in 
a minimum of synthetic steps, compared to conventional protection and 
deprotection strategies.  
This chapter describes the challenges and opportunities of this strategy.  
CATALYTIC SYSTEM 
The catalytic system developed by Waymouth et al. was originally 
designed for aerobic alcohol oxidation. The oxidation using molecular 
oxygen however was shown to be rather slow, even at a high catalyst 
loading of 10 mol%.[1] Although high initial reaction rates were observed, 
the catalyst loses activity rather fast. The reason for the decrease in 
catalytic activity was shown to be the oxidation of the ligand, as shown in 
Scheme 1.[2] Oxidation of a methyl substituent via C-H insertion of Pd(II) 
hydroperoxide, followed by subsequent further oxidation, forms complex 
6, which is inactive. With other terminal oxidants, such as benzoquinone, 
oxidation of the ligand is much slower and the reaction rate therefore 
considerably enhanced. The use of oxygen (preferably air), however, still 
is highly desirable. This holds, in particular, for our application, as it 
would simplify the purification of the products. 




Scheme 1 Proposed ligand oxidation as described by Waymouth et al.. Scheme was 
reproduced from the literature.[3] 
In 2011, Waymouth reported a more stable oxidation catalyst and studied 
it with 2-heptanol as the substrate. A 1:1 mixture of 7 and 8, which is 
expected to give in situ a complex similar to 2, doubled the turnover 
number at the same initial rates, compared to catalyst 1 and no sign of 
ligand oxidation was observed. However, full conversion using 3 mol% 
palladium, even with elongated reaction times using oxygen as terminal 
oxidant, was not obtained.[3] The authors observe small amounts of 
palladium black, and reason that this in itself should not be responsible 
for the fast drop in catalytic activity. The formation of catalytically 
inactive palladium nanoparticles however cannot be excluded. Another 
reason could be that the lack of a (methyl) substituent at the 9-position 
hampers the formation of the monomeric species. Notably 2-methyl 
phenanthroline, though readily prepared, was not reported by 
Waymouth as an alternative or compared with the trifluoromethyl 
analogue. On the other hand, the trifluoromethyl substituent also has a 




Figure 1 Oxidation-resistant complexes described by Waymouth et al.[3] (The presence 
of the 3-methyl substituent is due to synthetic reasons) 
Deuteration as protection 
In order to increase the stablility of the ligand, we were intrigued by two 
reports of Clayden et al. and Wood et al.. Clayden used deuterium to 
control the regioselectivity in lithiation reactions (ortho- vs. lateral-
lithiation vs. nucleophilic addition),[4] and Wood showed good 
selectivities in radical reactions involving hydrogen atom transfer.[5] 
Based on these reports, we envisioned that deuteration of the ligand 
might enhance the stability of the catalyst against the oxidation. 
The deactivation of the catalyst is, as described above, caused by a CH 
activation and further oxidation of the methyl substituents of the catalyst. 
By deuterium exchange of the hydrogens of the methyl groups of the 
catalyst, we believe to benefit from the kinetic isotope effect. The lower 
zero point energy of the deuterium-carbon bond compared to the 
hydrogen-carbon bond results in a higher activation energy for bond 
cleavage. Consequently the deuterated catalyst should be more stable. 
Perdeuteration of neocuproine was carried out according to a procedure 
of the Vos group for similar substrates and assisted by its first author.[6] 
Treatment of 9 with aqueous sodium deuteroxide (prepared by adding 
sodium to D2O) at 200 °C for 4 days in a teflon cup contained in a general 
purpose dissolution bomb gave deuterated neocuproine (10) in 98% 
isolated yield. The degree of deuteration was determined by NMR using 
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the residual solvent peak as internal standard at known concentrations. 
The degree of deuteration is indicated in Scheme 2. 
 
Scheme 2 Deuteration of neocuproine, the degree of deuteration is indicated 
The deuterated catalyst could be synthesized analogous to the non-
deuterated variant.[2] Complexation of ligand 10 with palladium acetate, 
followed by treatment with triflic acid and subsequent complexation of 
11 and 12 gave 13 in 35% overall yield (Scheme 3). Chemical shifts of the 
residual NMR peaks were identical to the non-deuterated variant 1. 





Scheme 3 Synthesis of the perdeuterated catalyst 13 
Both the deuterated catalysts 13 and the native catalyst 1 were 
recrystallized by vapor diffusion crystallization and analyzed by 
elemental analysis to ensure the purity of the complexes. Although 1 was 
pure according elemental analysis, the elemental analysis of 13, corrected 
for deuterium, was off, indicating impurities.  
Nevertheless, to test our hypothesis, the oxidation of methyl α-D-
glucopyranoside was followed over time by NMR. First, the influence of 
the deuteration of the catalyst was studied using 0.1 mol% of either native 
1 or deuterated 13 and benzoquinone as terminal oxidant.  




Scheme 4 Oxidation of methyl α-D-glucopyranoside 
In Table 1 the results of the oxidation using benzoquinone as terminal 
oxidant are shown. The conversion is, within experimental error, the same 
for both 1 and 13 at a series of time points. It was, however, unclear 
whether the effect of perdeuteration was not significant or that catalyst 
deactivation in the case of benzoquinone does not take place via C-H 
activation of the neighbouring methyl group (C-H activation has been 












 5 10 15 30 60 100 165 22h 
1 1 (0.1) 6 13 19 33 52 66 84 >98 
2 13 (0.1) 5 14 18 33 50 63 81 >98 
 
Therefore, the oxidation was performed with oxygen as terminal oxidant. 
Two experiments were conducted, first using 2.5 mol% of catalyst 1 or 13 
on 0.1 mmol scale and second using 0.25 mol% on 4 mmol scale. From 
Table 2, it is evident that for both cases the deuterated catalyst 13 gives a 
higher conversion than the non-deuterated 1. Whereas the reaction with 
1 did not go to completion using 2.5 mol% even after 48 h, 13 showed 
complete conversion already after 24 h. In entry 3 and 4 the catalyst 
loading was reduced to 0.25 mol% in order to compare the maximum 
turnover number. Here, 13 gives 36% conversion after 10 days compared 
to only 23% conversion for 1. In terms of total turnover number this is an 
increase by a factor of 1.5 (72 for 13 and 46 for 1). 







 0.25 0.75 1.5 4 24 48 144 240 
1 1 (2.5) 12 19 28 52 61 73   
2 13 (2.5) 22 30 44 85 >98    
3 1 (0.25)       20 23 
4 13 (0.25)       33 36 
 
These findings suggest that the perdeuterated complex is more stable 
than the non-deuterated variant. The results, however, are preliminary. 
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For a fair comparison that minimizes experimental error, several issues 
have to be resolved. First of all, the purity of both complexes has to be 
confirmed by elemental analysis. Second, the design of the experiments 
to confirm an increased stability of the deuterated complex should be 
more robust. In addition, in order to compare the results to the results of 
Waymouth et al., 2-heptanol should be included as the substrate. This has 
the advantage also that conversion can be readily determined by GC, 
contrary to the oxidation of methyl glucopyranoside. Finally, one desires 
to know whether the increased stability of the ligand/catalyst is indeed 
due to slower C-D activation by palladium (II). 
Sure, the problem of ligand oxidation will not be solved by this strategy, 
just somewhat relaxed. It is however an efficient approach that avoids the 
challenging design of an (entirely) new catalyst. 
Is this catalyst unique? 
A question that threaded the entire research is whether the Waymouth 
catalyst was unique in its selectivity, and connected to this whether 
different catalysts might show a deviating selectivity. The observed 
selectivity could be caused by a specific interaction/coordination of the 
complex to the glycoside. Therefore, some complexes have been tested in 
the oxidation to see whether there was a change in the selectivity. The 
complexes 16 and 17, described by Sigman et al.[7,8] for palladium 
catalyzed alcohol oxidation, were studied in the oxidation of methyl α-
glucopyranoside. Unfortunately, both did not show any reaction in a 




Figure 2 Catalysts for palladium catalyzed alcohol oxidation as described by Sigman et 
al.[7,8] 
Next, we wondered whether palladium bis(arylimino)-acenaphthene 
(BIAN) catalysts would be active in the selective oxidation of glycosides 
and would be maybe more stable than 1. Our group previously reported 
that these catalysts are considerably more active in the oxidative Heck 
reaction than neocuproine-based catalysts.[9] Therefore two complexes, 18 
and 19, were synthesized analogous to the phenanthroline ligands. 
Treatment of methyl α-D-glucopyranoside (14) with a 1:1 mixture of 18 
and 19 (1.25 mol% each) and benzoquinone as terminal oxidant in 
dioxane/DMSO (4:1) gave approximately 9% conversion at 60 °C in 24 h. 
Although the catalyst was apparently poorly active, its selectivity was 
high; 15 was observed as the single oxidation product. 
 
Scheme 5 Oxidation of methyl α-D-glucopyranoside using a Pd/BIAN catalyst 
The reactivity of the BIAN-based catalyst might be increased by using 
differently substituted anilines to prepare the ligand.[10,11] The backlog 
with neocuproine, however, is large and as the regioselectivity seems to 
be the same, there is not too much incentive.  
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Apart from BIAN-ligands, other ligands can be envisioned. 2-methyl 
phenanthroline (20) could benefit from the fact that only one methyl is 
accessible for the deactivation by oxidation and therefore should be more 
stable than neocuproine. In combination with the deuteration strategy 
mentioned above, a fairly stable complex should be feasible.  
Sheldon et al. published a palladium catalyzed alcohol oxidation in 
water.[12,13] The water soluble palladium acetate complex of 21 oxidized a 
range of primary and secondary aliphatic and benzylic substrates using 
low catalyst loadings (0.1-0.5 mol%) and oxygen as terminal oxidant. 
However, high temperatures (100 °C) and a high oxygen pressure (30-
60 bar, 8% O2 in N2) were necessary for these oxidations.  
This method could be studied in the selective oxidation of glycosides as 
well. The prospect that carbohydrate oxidation could be carried out in 
water is attractive, since the solubility of glycosides in water is usually 
high, and avoiding DMSO would be a huge advantage from a purification 
point of view. Furthermore, the use of oxygen as terminal oxidant would 
simplify the oxidation protocol even further.  
 




SUBSTRATES FOR THE SELECTIVE OXIDATION 
Glucosides 
In order to increase the substrate scope of the selective oxidation and to 
get further insight into the origin of the selectivity, several (partially 
protected) substrates are proposed here. In the earlier chapters we already 
studied variation on the C1, C2 and the C6 position of glucopyranosides 
(Chapter 2 & 3), which turned out not to influence the selectivity, but 
sometimes influenced the reaction rate (Chapter 3). Until now, we did not 
vary at the C4 position (except for benzyl protection), therefor it would be 
interesting to look at substrates 22-24 in terms of reaction speed and 
selectivity. The 4-deoxy derivative 22 should still be selective on C3 
similar to the 2-deoxy-variant. The 4-tetrahydropyranyl protected 23 is a 
mimic of the disaccharides we successfully oxidized selectively on the 
terminal ring. Here it would be interesting to see whether this compound 
is selectively oxidized and whether there is an influence on the rate of the 
reaction. Finally, modification on C4 with an electron withdrawing 
substituent such as benzoyl, 24 could give insights in the electronic 
influence of the 4-position.  
 
Figure 4 Possible substituents on C4 
In order to complete the reaction scope on C6, either glucoronic acid 
derivative 25 or 26 could be tested in order to see whether there is an 
electronic influence. For the same reason azide 27 should be tested, here 
it would be interesting to see whether a change in reaction speed could be 
observed. Furthermore, 27 could be a valuable intermediate in the design 
of biological probes, hence the ability to use “click”-chemistry. 




Figure 5 Possible modifications on C6 and C2 
Natural sweeteners 
Due to the growing problem of obesity and the connected health risks 
such as cardiovascular diseases and diabetes, sweeteners are an 
important non-caloric substitute for carbohydrates as sucrose and glucose 
in the food industry. A general problem is the bitter “off” taste of some 
natural sweeteners, which is accompanied with their sweetness.[14] Apart 
from their sweet taste, natural sweeteners also have shown biological 
activity and are therefore good candidates for target identification. Since 
most of the natural sweeteners are commercial available on multigram 
scale, they are ideal substrates for the selective oxidation. 
Representatives of natural sweeteners are depicted in Figure 6: 
Glycyrrhizin (29), isolated from the extract of Glycyrrhiza glabra root 
(liquorice), has been used for treatment of hepatitis C.[15] Mogrosides, the 
major compounds of Momordica grosvenori extracts with mogroside V (31) 
as main component, have shown to possess anti-inflammatory,[16] anti-
diabetic[17] and anti-cancer activity.[18] Another class of natural sweeteners 
are the steviol glycosides from the leafs of the Stevia rebaudiana plant. The 
main representative is Stevioside (30) among up to 10 other steviol 
glycosides. Unfortunately, the steviol glycosides and also the morgrol 




Figure 6 Natural sweeteners containing glucoside residues 
All of the structures contain one or more glucopyranose units, which 
could in principal be derivatized via selective oxidation. This opens new 
opportunities in order to synthesize more potent sweeteners (prevent 
bitter taste) or to study their biological activity (biochemical probes, 
radioactive labeling etc.).  
As an example, the natural sweeteners could be equipped via the keto 
group with a photoactivatable diazirine group (Scheme 6).[19] Diazirines 
have been used by the Cravatt group for example to identify cholesterol 
interacting proteins.[20] In a similar approach the natural sweetener could 
be used to further identify their biological targets and investigate their 
anti-inflammatory,[16] anti-diabetic[17] and anti-cancer activity.[18] 
 
Scheme 6 Proposed synthesis of photoactivatable diazirine probes based on natural 
sweeteners[19] 




Next to the selective oxidation of neomycin B, amikacin and kanamycin B 
described in the previous chapter, streptomycin should definitely be 
subjected to the selective oxidation after suitable amine and guanidine 
protection. Streptomycin (32) is also susceptible for “detoxification” by 
aminoglycoside modifying enzymes such as APH(3’’) and ANT(3’’). 
Therefore, selective oxidation and further modification could possibly 
circumvent these mechanisms of bacterial resistance while maintaining 
(part of) the antibiotic activity.  
 
Scheme 7 Modification of the 3''-position of streptomycin 
ORIGIN OF THE REGIOSELECTIVITY 
Up to now the origin of the selectivity it not clear, but one of the following 
hypotheses seems to be likely: 
1. Kinetic coordination of the most nucleophilic hydroxyl group of the 
glycoside to the palladium complex is the product-determining step.  
To test this hypothesis, substrates 37 and 38 should be studied. These 
substrates contain electron withdrawing β-substituents on the anomeric 
center, in the W-type conformation with respect to the C3-hydroxyl 
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group. This could increase the acidity of the hydroxyl group and should 
result in a loss or even a change in selectivity. 
 
Figure 7 Substrates with electron withdrawing substituents in β-position 
2. β-Hydride elimination of the CH bond at C3 is the fastest to occur.  
Quantum chemical calculations of the heterolytic bond dissociation 
energies of the CH bonds at C2, C3, C4 and C6 could give insight into this. 
In order to draw conclusions about the origin of the selectivity, more 
mechanistic experiments should be done. Up to now it is unclear what the 
rate determining step of the oxidation is. Analogous to the work of 
Waymouth it would be expected that the rate determining step is the β-
hydride elimination, but the kinetic coordination to the palladium 
complex as rate- or product- determining step is a reasonable explanation 
as well.  
Kinetic isotope effect measurements could be helpful to identify the rate 
limiting step. Methyl β-D-glucopyranoside deuterated at C3 should be 
readily available by reduction of 39 with sodium borodeuteride. The 
typically obtained 1:1 mixture[21] of methyl glucose and methyl allose is 
separable by column chromatography.  
 
Scheme 8 Synthesis of C3-deuterated methyl β-D-glucopyranoside 




In conclusion, the selective oxidation opens exciting and diverse 
opportunities for the modification of glycosides, aminoglycosides and 
natural sweeteners for a variety of purposes. Furthermore the catalytic 
system can be optimized in the future by the application of more stable 
catalysts enabling the use of molecular oxygen as sole oxidant. The 
strategy to use deuteration to protect the ligand from oxidation is 
unprecedented, and has to be verified in the future. 
EXPERIMENTAL SECTION 
General Information 
Solvents and Reagents 
All solvents used for extraction, filtration and chromatography were of 
commercial grade, and used without further purification. Reagents were 
purchased from Sigma-Aldrich, Acros, ABCR, and Carbosynth and were used 
without further purification. For purification via column chromatography silica 
gel from either Silicycle (Sila Flash 40-63 µm, 230-400 mesh). 16[7,8] and 18[9] were 
synthesized according to literature procedures.  
Analysis 
TLC was performed on Merck silica gel 60, 0.25 mm plates and visualization was 
done by UV and staining with Seebach’s reagent (a mixture of phosphomolybdic 
acid (25 g), cerium (IV) sulfate (7.5 g), H2O (500 mL) and H2SO4 (25 mL)) and 
potassium permanganate stain (a mixture of KMnO4 (3g), K2CO3 (10g), water 
(300mL)). 
1H-, 13C-, APT-, COSY-, HSQC-, NOESY were recorded on a Varian AMX400 (400, 
100.59 MHz, respectively) using DMSO-d6, MeOD-d4 or D2O as solvent. Chemical 
shift values are reported in ppm with the solvent resonance as the internal 
standard (DMSO-d6: 2.50 for 1H, δ 39.51 for 13C; MeOD-d4: δ3.31 for 1H, δ 49.15 for 
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13C; D2O: δ 4.80 for 1H; acetonitrile-d3: δ 1.94 for 1H, δ 118 for 13C). Data are 
reported as follows: chemical shifts (δ), multiplicity (s = singlet, d = doublet, t = 
triplet, q =quartet, br = broad, m = multiplet), coupling constants J (Hz), and 
integration.  
2,9-Dimethyl-1,10-phenantroline-d12 (10) 
The reaction was carried out using a teflon cup contained 
in a general purpose dissolution bomb. 2,9-dimethyl-1,10-
phenantroline (1 g, 4.8 mmol, 1 eq) was reacted at 200 °C 
in 20 mL of 1 M NaOD/D2O for 4 days. The water layer was 
extracted with DCM (20 mL). The organic layer was dried 
with Na2SO4, and the solvent removed in vacuo to give the 
deuterated 2,9-dimethyl-1,10-phenantroline (981 mg, 4.48 mmol, 93%). 
The extent of isotope exchange (see above) was determined by comparison of the 
1H NMR spectra of the product with the 2,9-dimethyl-1,10-phenantroline at 
known concentration using the residual solvent peak as an internal standard. 1H 
NMR (400 MHz, CDCl3): δ = 8.07 (s), 7.65 (s), 7.44 (s), 2.88 (m). 13C NMR (101 
MHz, CDCl3): δ = 159.4, 145.4, 135.9, 126.8, 125.4, 123.5, 25.2. HRMS (ESI) 
calculated for C14HD12N2 ([M+H]+): 221.183, found: 221.182. 220.176 (100%), 
221.182 (80%), 219.170 (54%), 218.164 (16%) 
(2,9-Dimethyl-1,10-phenantroline-d12)Pd(OAc)2 (11) 
Pd(OAc)2 (400 mg, 1.78 mmol, 1.0 eq) was dissolved in dry 
toluene (35 mL) and 2,9-dimethyl-1,10-phenantroline deuterated 
(408 mg, 1.96 mmol, 1.1 eq) was added as a solution in dry CH2Cl2 
(7 mL). The mixture was stirred during 24 h, a yellow precipitate 
formed. Pentane (15 mL) was added, and the precipitate was 
filtered, washed 3 times with pentane (5 mL) and dried in vacuo to give (2,9-
dimethyl-1,10-phenantroline deuterated)Pd(OAc)2 (716 mg, 1.61 mmol, 91%) as 
a brownish solid, which contained 40 mol% DCM according to NMR. 1H NMR 
(400 MHz, CDCl3): δ = 8.35 (s, 0.05H), 7.85 (s, 0.6H), 7.44 (s, 0.2H), 2.88 (br s, 
0.17H), 2.05 (s, 6H). 13C NMR (101MHz, CDCl3): δ = 178.7, 165.4, 147.6, 138.0, 
127.9, 126.9, 126.2, 24.0 (br), 23.1. Elemental analysis Calculated for 
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C18H7D11N2O4Pd, 40 mol% DCM: C, 46.16; H, 3.96.12; N, 5.85. Found: C, 44.68; H, 
4.01; N, 5.83. 
(2,9-Dimethyl-1,10-phenantroline-d12)Pd(MeCN)2(OTf)2 (12) 
(2,9-dimethyl-1,10-phenantroline-d12)Pd(OAc)2 
(350 mg, 0.79 mmol, 1 eq) was suspended in dry 
acetonitrile (1.5 mL) and a solution of 
trifluoromethanesulfonic acid (6 mL, 2.25 mmol, 
2.5 eq, 0.3 M in dry acetonitrile) was added. The 
mixture was carefully heated until all solids dissolved 
and then allowed to cool down to room temperature. A yellow solid precipitated. 
Et2O (6 mL) was added and the mixture stirred for 10 min. The yellow solid was 
filtered, washed twice with Et2O (2 mL), and dried in vacuo to give (2,9-dimethyl-
1,10-phenantroline-d12)Pd(MeCN)2(OTf)2 (331 mg, 0.47 mmol, 59%) as a slightly 
yellow solid. 1H NMR (400 MHz, CD3CN): δ = 8.69 (s, 0.05H), 8.09 (s, 0.6H), 7.78 
(s, 0.2H), 2. 97 (br s, 0.16H), 1.96 (s, 6H). 13C NMR (101 MHz, CD3CN): δ = 167.1, 
149.2, 141.7, 130.4, 128.4, 127.8. 
[(2,9-Dimethyl-1,10-phenantroline-d12)Pd(µ-OAc)]2(OTf)2 (13) 
(2,9-Dimethyl-1,10-phenantroline-d12)Pd(OAc)2 
(186 mg, 0.42 mmol, 1 eq) and (2,9-dimethyl-1,10-
phenantroline-d12)Pd(MeCN)2(OTf)2 (300 mg, 
0.42 mmol, 1 eq) were stirred in dry acetonitrile 
(25 mL) until all solids dissolved. Et2O (60 mL) was 
added to precipitate the complex. The orange 
complex was filtered, washed twice with Et2O (5 mL) and dried in vacuo to give 
[(2,9-dimethyl-1,10-phenantroline-d12)Pd(µ-OAc)]2(OTf)2 (300 mg, 0.28 mmol, 
65%). Addition of Et2O (80 mL) to the mother liquor gave an additional 121 mg 
which was impure according to NMR. 1H NMR (400 MHz, 298 K, CD3CN, dimer 
peaks): 8.26 (0.12H), 7.70 (1.50H), 7.38 (0.52H), (2.59, 0.36H), 2.25 (s, 6H). 13C 
NMR  (101 MHz, CD3CN, dimer peaks): δ = 183.2, 166.6, 146.7, 140.7, 129.5-
126.3, 23.9. 19F NMR  (376 MHz, CD3CN): δ = 79.2. Elemental analysis: 
Calculated for C34H8D22N4O10S2Pd2F6: C, 38.25; H, 2.83; N, 5.25; S, 6.01 Found: C, 





18 (100 mg, 0.16 mmol, 1 eq) was suspended in dry 
acetonitrile (1 mL) and triflic acid (0.62 mL, 0.66 M in 
acetonitrile, 0.4 mmol, 2.5 eq) was added. The mixture 
was carefully warmed by a heat gun until all solids 
dissolved and was allowed to reach rt. Et2O (15 mL) 
was added to precipitate 19 as an orange solid. The solid was filtered, washed 
with Et2O and dried in high vacuum overnight to give pure 19 according to NMR 
(104 mg, 0.12 mmol, 73%). 1H NMR (300 MHz, Acetonitrile-d3): δ = 8.40 (d, J = 8.4 
Hz, 2H), 7.69 (appears as t, J = 7.9 Hz, 2H), 7.60 – 7.47 (m, 2H), 7.40 (d, J = 7.5 Hz, 
4H), 6.87 (d, J = 7.3 Hz, 2H), 2.57 (s, 12H), 1.99 – 1.92 (m, 6H). 19F NMR (189 MHz, 
Acetonitrile-d3): δ = 79.4. 
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